Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 2, 2009, Pages 279-285

  Pergam, Steven A ^b   Schmidt, Darren W ^c   Nofchissey, Robert A ^a   Hunt, William C ^d   Harford, Antonia H ^e   Goade, Diane E ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HANTAVIRUS CARDIOPULMONARY SYNDROME; HANTAVIRUS PULMONARY SYNDROME; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; MALE; MEDICAL ASSESSMENT; PROTEINURIA; SEX RATIO; SURVIVOR; URINALYSIS; ADOLESCENT; CHRONIC DISEASE; HANTAVIRUS; HOSPITALIZATION; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; VIROLOGY;

HANTAVIRUS;

ADOLESCENT; ADULT; CHRONIC DISEASE; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 59649117427     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.279     Document Type: Article

References (51)

1. Bruno P, Hassell LH, Brown J, Tanner W, Lau A, 1990. The protean manifestations of hemorrhagic fever with renal syndrome. A retrospective review of 26 cases from Korea. Ann Intern Med 113: 385-391.
2. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A, 2003. Hantavirus infections in Europe. Lancet Infect Dis 3: 653-661.
3. Mckee K, LeDuc J, Peters CJ, 1991. Hantaviruses. Belshe RB, ed., Textbook of Human Virology. St. Louis: Mosby Year Book, 615-632.
4. Khan A, Khan AS, 2003. Hantaviruses: a tale of two hemispheres. Panminerva Med 45: 43-51.
5. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET, Moolenaar RL, Reef SE, Nolte KB, Gallaher MM, Butler JC, Breiman RF, for the Hantavirus Study Group, 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med 330: 949-955.
6. Settergren B, 2000. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis 32: 125-132.
7. Faulde M, Sobe D, Kimmig P, Scharninghausen J, 2000. Renal failure and hantavirus infection in Europe. Nephrol Dial Transplant 15: 751-753.
8. Cosgriff TM, 1991. Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 13: 97-107.
9. Mustonen J, Helin H, Pietila K, Brummer-Korvenkontio M, Hedman K, Vaheri A, Pasternack A, 1994. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 41: 121-126.
10. Makela S, Ala-Houhala I, Mustonen J, Koivisto AM, Kouri T, Turjanmaa V, Vapalahti O, Vaheri A, Pasternack A, 2000. Renal function and blood pressure five years after puumala virus-induced nephropathy. Kidney Int 58: 1711-1718.
11. Rubini ME, Jablon S, Mc DM, 1960. Renal residuals of acute epidemic hemorrhagic fever. Arch Intern Med 106: 378-387.
12. Miettinen MH, Makela SM, Ala-Houhala IO, Huhtala HS, Koobi T, Vaheri AI, Pasternack AI, Porsti IH, Mustonen JT, 2006. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int 69: 2043-2048.
13. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B, 2000. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 182: 43-48.
14. Hjelle B, Jenison S, Torrez-Martinez N, Herring B, Quan S, Polito A, Pichuantes S, Yamada T, Morris C, Elgh F, Lee HW, Artsob H, Dinello R, 1997. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 35: 600-608.
15. Centers for Disease Control and Prevention, Hantavirus Pulmonary Syndrome Labratory-confirmed Diagnosis. Available at: http://www.cdc.gov/ ncidod/diseases/hanta/hps/noframes/hpsslideset/hpsslidesl3-24.htm. Accessed June 14, 2008.
16. Centers for Disease Control and Prevention, 1997. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 46: 1-55.
17. Cockcroft DW, Gault MH, 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
18. Silkenson J, Kasiske B, 2004. Laboratory assessment of kidney disease. Brenner B, ed., Brenner and Rector's Textbook of Nephrology. Phildelphia: Saunders, 1107-1128.
19. Korevaar JC, Jansen MA, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT, 2002. Evaluation of DOQI guidelines: early start of dialysis treatment is not associated with better health-related quality of life. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 39: 108-115.
20. Torrez-Martinez N, Bharadwaj M, Goade D, Delury J, Moran P, Hicks B, Nix B, Davis JL, Hjelle B, 1998. Bayou virus-associated hantavirus pulmonary syndrome in Eastern Texas: identification of the rice rat, Oryzomys palustris, as reservoir host. Emerg Infect Dis 4: 105-111.
21. Hjelle B, Goade D, Torrez-Martinez N, Lang-Williams M, Kim J, Harris RL, Rawlings JA, 1996. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 23: 495-500.
22. Crowley MR, Katz RW, Kessler R, Simpson SQ, Levy H, Hallin GW, Cappon J, Krahling JB, Wernly J, 1998. Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 26: 409-414.
23. Glass GE, Watson AJ, LeDuc JW, Kelen GD, Quinn TC, Childs JE, 1993. Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis 167: 614-620.
24. Glass G, Childs JE, Watson AJ, LeDuc JW, 1990. Association of chronic renal disease, hypertension, and infection with a ratborne hantavirus. Arch Virol Suppl 1: 69-80.
25. Botros BA, Sobh M, Wierzba T, Arthur RR, Mohareb EW, Frenck R, El Refaie A, Mahmoud I, Chapman GD, Graham RR, 2004. Prevalence of hantavirus antibody in patients with chronic renal disease in Egypt. Trans R Soc Trop Med Hyg 98: 331-336.
26. Settergren B, Stegmayr BG, Elgh F, 1998. Lack of serologic evidence for an association between Hantavirus infection and end-stage renal disease. Nephron 80: 93.
27. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, Rollin PE, Ksiazek TG, Nichol ST, Mahy BWJ, Peters CJ, 1995. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552-579.
28. Dara SI, Albright RC, Peters SG, 2005. Acute sin nombre hantavirus infection complicated by renal failure requiring hemodialysis. Mayo Clin Proc 80: 703-704.
29. Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, Merlin TL, McFeeley PJ, Umland ET, Zumwalt RE, 1995. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 26: 110-120.
30. Khan AS, Gaviria M, Rollin PE, Hlady WG, Ksiazek TG, Armstrong LR, Greenman R, Ravkov E, Kolber M, Anapol H, Sfakianaki ED, Nichol ST, Peters CJ, Khabbaz RF, 1996. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med 100: 46-48.
31. Khan AS, Spiropoulou CF, Morzunov S, Zaki SR, Kohn MA, Nawas SR, McFarland L, Nichol ST, 1995. Fatal illness associated with a new hantavirus in Louisiana. J Med Virol 46: 281-286.
32. Passaro DJ, Shieh WJ, Hacker JK, Fritz CL, Hogan SR, Fischer M, Hendry RM, Vugia DJ, 2001. Predominant kidney involvement in a fatal case of hantavirus pulmonary syndrome caused by Sin Nombre virus. Clin Infect Dis 33: 263-264.
33. Basile DP, 2004. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 13: 1-7.
34. Block CA, Schoolwerth AC, 2006. The epidemiology and outcome of acute renal failure and the impact on chronic kidney disease. Semin Dial 19: 450-454.
35. Finn WF, 2001. Recovery for acute renal failure. Molitoris, BA, Finn, WF, eds., Acute Renal Failure: A Companion to Brenners and Rector's the Kidney. First edition. Philadelphia: WB Saunders, 425-450.
36. Taal M, Luyck V, Brenner B, 2004. Adaption to nephron losss. Brenner B, ed., Brenner and Rector's Textbook of Nephrology. Philadelphia: Saunders, 1954-1997.
37. Basile DP, Donohoe D, Roethe K, Osborn JL, 2001. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899.
38. Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J, 1992. Hantaan virus infection of human endothelial cells. J Virol 66: 5929-5936.
39. Yanagihara R, Silverman DJ, 1990. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol 111: 281-286.
40. Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER, 2002. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147: 1913-1931.
41. Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthofer H, 1996. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 78: 47-55.
42. Hayasaka D, Maeda K, Ennis FA, Terajima M, 2007. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 123: 120-127.
43. Schutt M, Meisel H, Kruger DH, Ulrich R, Dalhoff K, Dodt C, 2004. Life-threatening Dobrava hantavirus infection with unusually extended pulmonary involvement. Clin Nephrol 62: 54-57.
44. Sell LL, Cullen ML, Whittlesey GC, Lerner GR, Klein MD, 1987. Experience with renal failure during extracorporeal membrane oxygenation: treatment with continuous hemofiltration. J Pediatr Surg 22: 600-602.
45. Meyer DM, Jessen ME, 1995. Results of extracorporeal membrane oxygenation in neonates with sepsis. The Extracorporeal Life Support Organization experience. J Thorac Cardiovasc Surg 109: 419-425; discussion 425-427.
46. Kolla S, Awad SS, Rich PB, Schreiner RJ, Hirschl RB, Bartlett RH, 1997. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 226: 544-564; discussion 565-566.
47. Xiao R, Yang S, Koster F, Ye C, Stidley C, Hjelle B, 2006. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 194: 1403-1409.
48. Prescott J, Ye C, Sen G, Hjelle B, 2005. Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol 79: 15007-15015.
49. Dietl CA, Wernly JA, Pett SB, Yassin SF, Sterling JP, Dragan R, Milligan K, Crowley MR, 2008. Extracorporeal membrane oxygenation support improves survival of patients with severe hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg 135: 579-584.
50. Hogg RJ, 2005. Adolescents with proteinuria and/or the nephrotic syndrome. Adolesc Med Clin 16: 163-172.
51. Wingo CS, Clapp WL, 2000. Proteinuria: potential causes and approach to evaluation. Am J Med Sci 320: 188-194.